Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside

Biomarkers. 2011 Sep;16(6):466-75. doi: 10.3109/1354750X.2011.580006. Epub 2011 Jul 1.

Abstract

Context: Growth differentiation factor 15 (GDF-15) is a novel cytokine showing close association with cardiovascular diseases. The biological mechanism and clinical use of GDF-15 in cardiovascular diseases have been well demonstrated. We review recent investigations from both basic research and clinical trials into the biological role of GDF-15.

Methods: The data were obtained mainly from MedLine via PubMed and from our own investigations.

Results: Laboratory investigations revealed that GDF-15 has biphasic effects on cellular survival by several signaling pathways. GDF-15 participates in several cardiovascular pathological processes such as cardiac remodeling, ischemia/reperfusion injury and atherosclerotic plaque formation. As well, GDF-15 was found a prognostic biomarker of heart failure and acute coronary syndrome. The evidence for diagnostic or therapeutic utility is poor.

Conclusion: GDF-15 has great potential as a biomarker in cardiovascular diseases, especially for prognosis, and is seen as a myocardial protective cytokine, but the exact mechanism of GDF-15 in cardiovascular diseases remains unknown.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acute Coronary Syndrome / diagnosis*
  • Acute Coronary Syndrome / mortality
  • Acute Coronary Syndrome / pathology
  • Bibliographies as Topic
  • Biomarkers / metabolism
  • Cardiotonic Agents / metabolism
  • Cardiotonic Agents / pharmacology
  • Clinical Trials as Topic
  • Growth Differentiation Factor 15* / genetics
  • Growth Differentiation Factor 15* / metabolism
  • Growth Differentiation Factor 15* / pharmacology
  • Heart Failure / diagnosis*
  • Heart Failure / mortality
  • Heart Failure / pathology
  • Humans
  • Myocardial Infarction / diagnosis*
  • Myocardial Infarction / mortality
  • Myocardial Infarction / pathology
  • Plaque, Atherosclerotic / diagnosis*
  • Plaque, Atherosclerotic / mortality
  • Plaque, Atherosclerotic / pathology
  • Prognosis
  • Reperfusion Injury / diagnosis*
  • Reperfusion Injury / mortality
  • Reperfusion Injury / pathology
  • Risk Factors
  • Signal Transduction
  • Survival Rate
  • Ventricular Remodeling

Substances

  • Biomarkers
  • Cardiotonic Agents
  • Growth Differentiation Factor 15